‘Biden’s Health Secretary Gives Update On Marijuana Scheduling Review Directed By The President’ -Marijuana Moment
https://www.marijuanamoment.net/bidens-health-secretary-gives-update-on-marijuana-scheduling-review-directed-by-the-president/
‘On Marijuana Banking Bill, Congressman Is Balancing Optimism With Realism As Senate Talks Heat Up’ -Marijuana Moment Report
https://www.marijuanamoment.net/on-marijuana-banking-bill-congressman-is-balancing-optimism-with-realism-as-senate-talks-heat-up/
Valens Shareholders Vote In Favour Of Arrangement With SNDL
The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the "Company" or "Valens") is pleased to announce that its shareholders have voted in favour
Cantor Fitzgerald Maintains Neutral on SNDL, Raises Price Target to $3.6
Cantor Fitzgerald analyst Pablo Zuanic maintains SNDL (NASDAQ:SNDL) with a Neutral and raises the price target from $3.56 to $3.6.
Anti-Legalization Group Smart Approaches For Marijuana Bands Together With Law Enforcement, Parent Groups And Others To Ask The Senate Not To Pass The SAFE Banking Act
Natalie Fertig on Twitter: "Inbox: Anti-legalization group Smart Approaches for Marijuana bands together with law enforcement, parent groups and others to ask the Senate not to pass the SAFE Banking Act.
SNDL Renews Share Repurchase Program, SunStream Provides Additional Funding To SKYMINT
SNDL Inc. (NASDAQ: SNDL) announced that its board of directors has approved the renewal of the share repurchase program upon the expiry of
‘House Democrats And Republicans Publish ‘Joint Memo’ On Marijuana Ahead Of Congressional Legalization Hearing’ – Marijuana Moment
House Democrats And Republicans Publish 'Joint Memo' On Marijuana Ahead Of Congressional Legalization Hearing - Marijuana Moment
House Democrats and Republicans have co-published a joint memo ahead of a
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.